US nod for Lynparza in HRD-positive advanced ovarian cancer

Lynparza has been cleared for use as a first-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer

NICE backs Roche’s Kadcyla for HER2-positive early breast cancer

Around 800 people will be eligible for treatment with Kadcyla

AbbVie completes acquisition of Allergan

The move significantly expands and diversifies AbbVie’s revenue base

PM faces calls for inquiry into BAME COVID-19 death risk

Campaigners are urging the government to investigate the higher death risk from coronavirus for people with black, Asian […]

Day against Stroke 2020

This year on 10.05.2020 the Day Against Stroke is being celebrated under the title “The digital helpers are […]

CALCIUM ACETATE capsule [Cipla USA Inc.,]

Updated Date: Fri, 01 May 2020 00:00:00 EDT

DEGASA HAND SANITIZER LEMON LIME SCENT (alcohol) gel [Degasa, S.A. de C.V.]

Updated Date: Fri, 01 May 2020 00:00:00 EDT

IODOQUINOL 1% – HYDROCORTISONE ACETATE 2% – ALOE POLYSACCHARIDES 1% gel [Seton Pharmaceuticals]

Updated Date: Fri, 01 May 2020 00:00:00 EDT

ESSENTIALS BY URBAN SECRETS ADVANCED HAND SANITIZER (alcohol) gel [Pro’s Choice Beauty Care, Inc.]

Updated Date: Fri, 01 May 2020 00:00:00 EDT

ZICAM COLD REMEDY MEDICATED FRUIT DROPS (zinc acetate anhydrous and zinc gluconate) bar, chewable [Matrixx Initiatives, Inc.]

Updated Date: Fri, 01 May 2020 00:00:00 EDT